Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma?

Published:2011-03 Issue:1 Volume:23 Page:47-53
ISSN:1110-0362
Container-title:Journal of the Egyptian National Cancer Institute
language:en
Short-container-title:Journal of the Egyptian National Cancer Institute

Author:

Abdel Rahman Hany,Moussa Emad A.H.,Zekri Wael Z.K.,El Debawy Eman,Mostafa Naglaa E.,Yones Alaa,Ezzat Sameera,El Rahman Rayan Abd

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference26 articles.

1. The International Neuroblastoma Risk Groups (INRG): a preliminary report;Castleberry;Eur J Cancer,1997

2. Survival analysis of clinical, pathologic and genetic features in neuroblastoma presenting as locoregional disease;Mora;Cancer,2001

3. The international neuroblastoma pathology classification (the Shimada system);Shimada;Cancer,1999

4. Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry;Lode;Eur J Cancer,1997

5. Dose-intensity analysis and randomized trials;Heller;J Clin Oncol,1991

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Therapies for Relapsed and Refractory Neuroblastoma;Children;2018-10-31

2. Implementation of Personality Principle in the Termination of Village Ground Treasure Utilization No. 143/1728 Between PB. Rancah Karya and Catur Tunggal Village Government;SHS Web of Conferences;2018

3. Overview and recent advances in the treatment of neuroblastoma;Expert Review of Anticancer Therapy;2017-03-15

4. Ifosfamide, carboplatin, and etoposide for neuroblastoma;Cancer;2012-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3